Lifeward (LFWD) Net Income towards Common Stockholders (2015 - 2026)
Lifeward's (LFWD) quarterly Net Income towards Common Stockholders came in at -$10.8 million in Q1 2026, down 123.27% year-on-year from $46.4 million in Q1 2025, and down 101.81% quarter-over-quarter from -$5.3 million in Q4 2025.
Lifeward (LFWD) Net Income towards Common Stockholders (2015 - 2026) Analysis & Trends
Lifeward has disclosed Net Income towards Common Stockholders across 12 years of filings, most recently posting -$10.8 million for Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$10.8 million, down 123.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.9 million (up 5.92% YoY), and the FY2025 annual result was -$19.9 million, up 31.19% from the prior year.
- Net Income towards Common Stockholders came in at -$10.8 million for Q1 2026 at Lifeward, down from -$5.3 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$3.1 million in Q3 2024 to a low of -$15.3 million in Q4 2024.
- The 5-year median for Net Income towards Common Stockholders is -$5.3 million (2022), against an average of -$6.0 million.
- Across the five-year window, Net Income towards Common Stockholders sank 170.93% in 2024 and jumped 65.0% in 2025, its largest moves.
- Lifeward's Net Income towards Common Stockholders stood at -$5.3 million in 2022, then slipped by 6.14% to -$5.6 million in 2023, then tumbled by 170.93% to -$15.3 million in 2024, then surged by 65.0% to -$5.3 million in 2025, then plunged by 101.81% to -$10.8 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$10.8 million (Q1 2026), -$5.3 million (Q4 2025), and -$3.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Lifeward | 11.33 Mn | -74,887.59 | 1.34 Mn | -10.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.79 Mn |
| Dec 31, 2025 | -5.35 Mn |
| Sep 30, 2025 | -3.17 Mn |
| Jun 30, 2025 | -6.56 Mn |
| Mar 31, 2025 | -4.83 Mn |
| Dec 31, 2024 | -15.28 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Mar 31, 2024 | -6.28 Mn |
| Dec 31, 2023 | -5.64 Mn |
| Sep 30, 2023 | -7.53 Mn |
| Jun 30, 2023 | -4.64 Mn |
| Mar 31, 2023 | -4.32 Mn |
| Dec 31, 2022 | -5.31 Mn |
| Sep 30, 2022 | -5.46 Mn |
| Jun 30, 2022 | -4.45 Mn |
| Mar 31, 2022 | -4.35 Mn |
| Dec 31, 2021 | -3.86 Mn |
| Sep 30, 2021 | -2.68 Mn |
| Jun 30, 2021 | -3.14 Mn |